首頁 > 市場調查報告書 > 材料/化學品

市場調查報告書

商品編碼

2048127

菸鹼醯胺市場 - 全球產業規模、佔有率、趨勢、機會、預測：銷售管道、最終用途、地區和競爭格局，2021-2031年

Nicotinamide Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel, By End Use, By Region & Competition, 2021-2031F

出版日期: 2026年05月25日 | 出版商:

TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球菸鹼醯胺市場預計將從 2025 年的 7.1721 億美元大幅成長至 2031 年的 10.6313 億美元，複合年成長率為 6.78%。

菸鹼醯胺是維生素B3的重要水溶性形式，廣泛應用於醫藥、化妝品和動物飼料。此市場成長的主要驅動力是全球畜牧業對用於疾病預防的高性能飼料添加劑的需求顯著增加，以及皮膚疾病發病率的上升，這些疾病需要有效的皮膚屏障解決方案。此外，消費者對預防醫學日益成長的關注也導致維生素類營養補充劑的工業消費量大幅增加。然而，該市場面臨許多挑戰，尤其是在供應鏈不穩定和製造地集中方面。由於原料合成高度依賴區域生產，該市場極易受到貿易趨勢變化和物流延誤的影響，阻礙了穩定的採購。例如，歐洲飼料工業聯合會（EFF）報告稱，到2025年，歐盟將進口超過75%的維生素B3，這凸顯了全球生產集中帶來的巨大風險以及對相關產業的潛在衝擊。

市場概覽
預測期	2027-2031
市場規模：2025年	7.1721億美元
市場規模：2031年	1,063,130,000 美元
複合年成長率：2026-2031年	6.78%
成長最快的細分市場	製藥
最大的市場	亞太地區

市場促進因素

全球菸鹼醯胺市場正經歷重大變革，這主要得益於人們對菸鹼醯胺改善皮膚屏障功能和減少色素沉著功效的認可，從而帶動了藥用化妝品和抗衰老護膚品需求的成長。化妝品製造商正積極將高純度維生素B3（菸鹼醯胺）添加到各種精華液和乳霜中，以滿足追求多功能活性成分的精明消費者的需求。這一趨勢也得到了消費者強勁需求的支撐。 2025年11月，基金會發布的報告《2024年頂級護膚成分新數據》將菸鹼醯胺列為搜尋第四高的護膚成分，證實了其在現代美容護膚流程中與視網醇等成熟成分並駕齊驅的重要地位。這種持續的熱銷促使化學品供應商提高了化妝品級菸鹼醯胺的產量，以滿足個人護理行業嚴格的純度標準。同時，動物飼料產業的擴張也推動了市場成長。全球畜牧業的擴張推動了這一趨勢，菸鹼醯胺已成為促進家禽和豬代謝健康、預防疾病的重要添加物。隨著全球肉類消費量的成長，飼料維生素的工業需求也在上升，這對於確保畜群的最佳生產性能和食品安全至關重要。根據Alltech發布的《2025年農業食品展望》（2025年11月），2024年全球飼料產量將增加1.2%，達到13.96億噸，這將直接導致對維生素B3的需求增加。此外，dsm-firmenich在2025年2月發布的報告進一步印證了該行業的強勁勢頭：其動物營養與健康部門在2024年實現了5%的有機銷售成長，展現了動物營養行業的商業性活力。

市場挑戰

全球菸鹼醯胺市場面臨擴張的重大障礙，其根源在於製造地高度集中在特定地區。這種對少數區域生產基地的過度依賴，造成了脆弱的供應鏈結構，使其極易受到監管變化、物流中斷等局部事件引發的供應問題的影響。因此，下游產業常常遭受價格大幅波動和原物料供應不穩定的衝擊，阻礙了長期成長計畫的製定，也妨礙了市場所需的穩定發展。近期貿易統計數據清楚地顯示了這種結構性缺陷的嚴重性，這些數據凸顯了對特定出口來源的依賴。根據中國醫藥保健品進出口商會的數據，預計2024年中國維生素出口總額將達到約34.5億美元，其中僅從美國進口的就高達8.4億美元。這一數字凸顯了一個關鍵瓶頸，即全球供應穩定性基本上依賴於單一國家的生產能力，從而導致風險環境，阻礙投資並降低全球分銷體系的效率。

市場趨勢

製造商正逐步從傳統的化學合成轉向環境友善生物製造技術，特別是採用化學酵素法和微生物發酵製程的技術。這項轉變旨在減少對環境的影響，並確保符合監管標準。這種策略轉變與典型的供應鏈變革顯著不同，其核心目標是最大限度地減少生產的碳足跡，從而吸引具有永續性意識的相關人員。產業領導者正透過嚴格的檢驗框架正式確立這些努力，確保其製造創新符合全球氣候變遷標準。例如，龍沙公司發布的《2024年永續發展報告》（2025年4月）確認，其短期溫室氣體減量目標已於2024年獲得科學碳目標計劃（SBTi）的檢驗。該公司承諾在2030年將其範圍1和範圍2的絕對排放減少42%，為環境高效的菸鹼醯胺生產樹立了新的標竿。同時，男士護理市場也正在顯著擴張。這一趨勢的驅動力在於人口結構的變化，男性消費者由於菸鹼醯胺不油膩且能增強皮膚屏障的特性，開始尋求功能性護膚成分。這一趨勢與更廣泛的藥用化妝品需求（即一般抗衰老配方）有所不同，它專門針對那些利用數位平台研究成分功效和選擇產品的男性消費者。這種日益成長的興趣體現在社群媒體的搜尋模式中，顯示出消費者對特定成分的關注。根據《化妝品商業》雜誌2025年7月發布的《男士趨勢報告》，男性Pinterest用戶對含菸鹼醯胺精華液的搜尋增加了35%，凸顯了該成分作為男性個人護理關鍵成分的重要性日益凸顯。

The global nicotinamide market is projected to expand significantly, rising from USD 717.21 million in 2025 to USD 1063.13 million by 2031, demonstrating a compound annual growth rate of 6.78%. Nicotinamide, a crucial water-soluble form of Vitamin B3, is widely incorporated into pharmaceutical products, cosmetic formulations, and animal nutrition. This market growth is primarily fueled by the increasing incidence of dermatological conditions that require effective skin barrier solutions, alongside the substantial growth of the global livestock industry's demand for high-performance feed additives for disease prevention. Additionally, a growing consumer focus on preventative healthcare significantly increases the industrial consumption of vitamin-based dietary supplements. However, the market faces considerable hurdles, particularly concerning supply chain instability and the concentrated nature of its manufacturing base. A strong dependence on specific regions for synthesizing raw materials makes the market susceptible to trade shifts and logistical delays, hindering consistent sourcing. For instance, the European Feed Manufacturers' Federation reported in 2025 that the European Union imported over 75% of its Vitamin B3, highlighting the substantial risks linked to centralized global production and potential disruptions for related industries.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 717.21 Million
Market Size 2031	USD 1063.13 Million
CAGR 2026-2031	6.78%
Fastest Growing Segment	Pharmaceuticals
Largest Market	Asia Pacific

Market Driver

The global nicotinamide market is undergoing a significant transformation driven by the escalating demand for cosmeceuticals and anti-aging skincare products, owing to the compound's recognized efficacy in improving skin barrier function and diminishing hyperpigmentation. Cosmetic companies are actively integrating high-purity Vitamin B3 into various serums and creams to satisfy a knowledgeable consumer base seeking versatile active ingredients. This trend is supported by substantial consumer engagement; a November 2025 Foundation report, 'New data reveals top skincare ingredients of 2024', identified Niacinamide as the fourth most searched skincare ingredient, affirming its crucial position in contemporary beauty routines alongside established compounds like retinol. This enduring popularity is prompting chemical suppliers to increase production of cosmetic-grade nicotinamide to fulfill the personal care sector's stringent purity standards. Concurrently, market growth is fueled by the expanding animal feed sector, propelled by global livestock production, where nicotinamide is a vital additive for enhancing metabolic health and preventing diseases in poultry and swine. With increasing global meat consumption, the industrial demand for feed-grade vitamins intensifies, crucial for ensuring peak herd performance and food security. The '2025 Agri-Food Outlook' by Alltech (November 2025) noted a 1.2% rise in global feed production in 2024, reaching 1.396 billion metric tons, which directly translates to greater Vitamin B3 procurement. Further underscoring this sector's strength, dsm-firmenich reported in February 2025 that their Animal Nutrition & Health unit achieved 5% organic sales growth in 2024, indicating strong commercial vibrancy within the livestock nutrition landscape.

Market Challenge

The global nicotinamide market encounters a major obstacle to its expansion stemming from the pronounced geographic centralization of its manufacturing operations. This profound dependence on a restricted number of regional production centers establishes a vulnerable supply chain structure, making it susceptible to widespread availability problems triggered by isolated local incidents like regulatory changes or logistical disruptions. As a result, downstream industries often experience significant price fluctuations and irregular raw material supplies, which impedes their capacity for long-term growth planning and destabilizes the consistent market evolution needed. The profound nature of this structural weakness is clearly demonstrated by recent trade statistics, which highlight the market's reliance on particular export sources. Data from the China Chamber of Commerce for Import & Export of Medicines & Health Products indicated that in 2024, China's total vitamin exports reached approximately USD 3.45 billion, with the U.S. market alone importing USD 840 million of this amount. This figure reveals a crucial bottleneck where global supply stability is intrinsically linked to the production capabilities of a single nation, thereby generating a risk landscape that discourages investment and introduces inefficiencies within the global distribution framework.

Market Trends

Manufacturers are progressively moving away from conventional chemical synthesis towards environmentally friendly biomanufacturing techniques, specifically employing chemo-enzymatic and microbial fermentation processes. This transition aims to reduce environmental impact and ensure adherence to regulatory standards. This strategic shift differs significantly from typical supply chain modifications, as its core objective is to minimize the carbon footprint of production to attract stakeholders focused on sustainability. Leading industry participants are formalizing these pledges with stringent validation frameworks, guaranteeing that their manufacturing innovations align with global climate benchmarks. For example, Lonza's 'Sustainability Report 2024' (April 2025) confirmed that its near-term greenhouse gas reduction targets were validated by the Science Based Targets Initiative in 2024, with a commitment to cut absolute Scope 1 and 2 emissions by 42% by 2030, thereby establishing a new standard for eco-efficient nicotinamide manufacturing. Concurrently, the market is experiencing a notable expansion into the male grooming segment, spurred by a demographic change where men are increasingly seeking functional skincare components such as Nicotinamide due to its non-greasy, barrier-reinforcing attributes. This trend is distinct from the wider cosmeceutical demand for general anti-aging formulations, as it specifically targets male consumers who leverage digital platforms to research ingredient effectiveness and product choices. This heightened engagement is reflected in social media search patterns indicating specific ingredient interest. A July 2025 'Men's Trends Report' by Cosmetics Business revealed a 35% increase in searches for niacinamide serum among male Pinterest users, underscoring the ingredient's growing prominence as a key component in men's personal care routines.

Key Market Players

Nebula Health Care
Suchem Laboratory
Western Drugs Limited
Roopa industries limited
S.V. Labs Pvt. Ltd.
Veer Chemie & Aromatics pvt ltd.
Optimus Drugs Pvt. Ltd
NIGAM FINECHEM PVT. LTD
Ishita Drugs & Industries Ltd
Anhui Redpont Biotechnology Co., Ltd

Report Scope

In this report, the Global Nicotinamide Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nicotinamide Market, By Sales Channel

Direct
Indirect

Nicotinamide Market, By End Use

Pharmaceuticals
Cosmetics & Personal Care
Food & Beverages
Animal Feed
Chemicals

Nicotinamide Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nicotinamide Market.

Available Customizations:

Global Nicotinamide Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Nicotinamide Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Sales Channel (Direct, Indirect)
- 5.2.2. By End Use (Pharmaceuticals, Cosmetics & Personal Care, Food & Beverages, Animal Feed, Chemicals)
- 5.2.3. By Region
- 5.2.4. By Company (2025)
5.3. Market Map

6. North America Nicotinamide Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Sales Channel
- 6.2.2. By End Use
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Nicotinamide Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Sales Channel
    - 6.3.1.2.2. By End Use
- 6.3.2. Canada Nicotinamide Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Sales Channel
    - 6.3.2.2.2. By End Use
- 6.3.3. Mexico Nicotinamide Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Sales Channel
    - 6.3.3.2.2. By End Use

7. Europe Nicotinamide Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Sales Channel
- 7.2.2. By End Use
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Nicotinamide Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Sales Channel
    - 7.3.1.2.2. By End Use
- 7.3.2. France Nicotinamide Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Sales Channel
    - 7.3.2.2.2. By End Use
- 7.3.3. United Kingdom Nicotinamide Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Sales Channel
    - 7.3.3.2.2. By End Use
- 7.3.4. Italy Nicotinamide Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Sales Channel
    - 7.3.4.2.2. By End Use
- 7.3.5. Spain Nicotinamide Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Sales Channel
    - 7.3.5.2.2. By End Use

8. Asia Pacific Nicotinamide Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Sales Channel
- 8.2.2. By End Use
- 8.2.3. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Nicotinamide Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Sales Channel
    - 8.3.1.2.2. By End Use
- 8.3.2. India Nicotinamide Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Sales Channel
    - 8.3.2.2.2. By End Use
- 8.3.3. Japan Nicotinamide Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Sales Channel
    - 8.3.3.2.2. By End Use
- 8.3.4. South Korea Nicotinamide Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Sales Channel
    - 8.3.4.2.2. By End Use
- 8.3.5. Australia Nicotinamide Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Sales Channel
    - 8.3.5.2.2. By End Use

9. Middle East & Africa Nicotinamide Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Sales Channel
- 9.2.2. By End Use
- 9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Nicotinamide Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Sales Channel
    - 9.3.1.2.2. By End Use
- 9.3.2. UAE Nicotinamide Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Sales Channel
    - 9.3.2.2.2. By End Use
- 9.3.3. South Africa Nicotinamide Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Sales Channel
    - 9.3.3.2.2. By End Use

10. South America Nicotinamide Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Sales Channel
- 10.2.2. By End Use
- 10.2.3. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Nicotinamide Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Sales Channel
    - 10.3.1.2.2. By End Use
- 10.3.2. Colombia Nicotinamide Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Sales Channel
    - 10.3.2.2.2. By End Use
- 10.3.3. Argentina Nicotinamide Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Sales Channel
    - 10.3.3.2.2. By End Use

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Nicotinamide Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Nebula Health Care
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Suchem Laboratory
15.3. Western Drugs Limited
15.4. Roopa industries limited
15.5. S.V. Labs Pvt. Ltd.
15.6. Veer Chemie & Aromatics pvt ltd.
15.7. Optimus Drugs Pvt. Ltd
15.8. NIGAM FINECHEM PVT. LTD
15.9. Ishita Drugs & Industries Ltd
15.10. Anhui Redpont Biotechnology Co., Ltd